Back to Search Start Over

Functional and Safety Outcomes of Carotid Artery Stenting and Mechanical Thrombectomy for Large Vessel Occlusion Ischemic Stroke With Tandem Lesions

Authors :
Mudassir Farooqui
Osama O. Zaidat
Ameer E. Hassan
Darko Quispe-Orozco
Nils Petersen
Afshin A. Divani
Marc Ribo
Michael Abraham
Johanna Fifi
Waldo R. Guerrero
Amer M. Malik
James E. Siegler
Thanh N. Nguyen
Sunil Sheth
Albert J. Yoo
Guillermo Linares
Nazli Janjua
Milagros Galecio-Castillo
Wondewossen G. Tekle
Victor M. Ringheanu
Marion Oliver
Giana Dawod
Jessica Kobsa
Ayush Prasad
Asad Ikram
Eugene Lin
Kristine Below
Cynthia B. Zevallos
Marta Olivé Gadea
Abid Qureshi
Andres Dajles
Stavros Matsoukas
Ameena Rana
Mohamad Abdalkader
Sergio Salazar-Marioni
Jazba Soomro
Weston Gordon
Juan Vivanco-Suarez
Charoskhon Turabova
Maxim Mokin
Dileep R. Yavagal
Mouhammad A. Jumaa
Santiago Ortega-Gutierrez
Institut Català de la Salut
[Farooqui M, Quispe-Orozco D] Department of Neurology, University of Iowa Hospitals and Clinics, Iowa City. [Zaidat OO] Department of Neurology, Saint Vincent Mercy Hospital, Toledo, Ohio. [Hassan AE] Department of Neurology, Valley Baptist Medical Center/University of Texas Rio Grande Valley, Harlingen. [Petersen N] Department of Neurology, Yale University School of Medicine, New Haven, Connecticut. [Divani AA] Department of Neurology, University of New Mexico Health Science Center, Albuquerque. [Ribo M, Gadea MO] Servei de Neurologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain
Vall d'Hebron Barcelona Hospital Campus
Source :
Scientia
Publication Year :
2023
Publisher :
American Medical Association, 2023.

Abstract

ImportanceApproximately 10% to 20% of large vessel occlusion (LVO) strokes involve tandem lesions (TLs), defined as concomitant intracranial LVO and stenosis or occlusion of the cervical internal carotid artery. Mechanical thrombectomy (MT) may benefit patients with TLs; however, optimal management and procedural strategy of the cervical lesion remain unclear.ObjectiveTo evaluate the association of carotid artery stenting (CAS) vs no stenting and medical management with functional and safety outcomes among patients with TL-LVOs.Design, Setting, and ParticipantsThis cross-sectional study included consecutive patients with acute anterior circulation TLs admitted across 17 stroke centers in the US and Spain between January 1, 2015, and December 31, 2020. Data analysis was performed from August 2021 to February 2022. Inclusion criteria were age of 18 years or older, endovascular therapy for intracranial occlusion, and presence of extracranial internal carotid artery stenosis (>50%) demonstrated on pre-MT computed tomography angiography, magnetic resonance angiography, or digital subtraction angiography.ExposuresPatients with TLs were divided into CAS vs nonstenting groups.Main Outcomes and MeasuresPrimary clinical and safety outcomes were 90-day functional independence measured by a modified Rankin Scale (mRS) score of 0 to 2 and symptomatic intracranial hemorrhage (sICH), respectively. Secondary outcomes were successful reperfusion (modified Thrombolysis in Cerebral Infarction score ≥2b), discharge mRS score, ordinal mRS score, and mortality at 90 days.ResultsOf 685 patients, 623 (mean [SD] age, 67 [12.2] years; 406 [65.2%] male) were included in the analysis, of whom 363 (58.4%) were in the CAS group and 260 (41.6%) were in the nonstenting group. The CAS group had a lower proportion of patients with atrial fibrillation (38 [10.6%] vs 49 [19.2%], P = .002), a higher proportion of preprocedural degree of cervical stenosis on digital subtraction angiography (90%-99%: 107 [32.2%] vs 42 [20.5%], P P = .003), a lower median (IQR) National Institutes of Health Stroke Scale score (15 [10-19] vs 17 [13-21], P P = .007), favorable shift in mRS scores (aOR, 1.46; 95% CI, 1.02-2.10; P = .04), and successful reperfusion (aOR, 1.70; 95% CI, 1.02-3.60; P = .002) were significantly higher for the CAS group compared with the nonstenting group. Both groups had similar odds of sICH (aOR, 0.90; 95% CI, 0.46-2.40; P = .87) and 90-day mortality (aOR, 0.78; 95% CI, 0.50-1.20; P = .27). No heterogeneity was noted for 90-day functional outcome and sICH in prespecified subgroups.Conclusions and RelevanceIn this multicenter, international cross-sectional study, CAS of the cervical lesion during MT was associated with improvement in functional outcomes and reperfusion rates without an increased risk of sICH and mortality in patients with TLs.

Details

Language :
English
Database :
OpenAIRE
Journal :
Scientia
Accession number :
edsair.doi.dedup.....b572885f8c97e81eda74d30c31735785